We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Takeda’s Patent Infringement Suit Not Antitrust-Proof

Law360 (December 20, 2018, 8:19 PM EST) -- Patent infringement lawsuits challenging generic drug applications aren’t automatically immune from antitrust claims, a New Jersey federal judge ruled Wednesday, refusing to toss counterclaims accusing Takeda Pharmaceutical Co. Ltd. of trying...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.